Advanced Accelerator Applications S.A. (NASDAQ:AAAP) has earned an average rating of “Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $62.00.
AAAP has been the subject of several recent analyst reports. Canaccord Genuity set a $47.00 target price on shares of Advanced Accelerator Applications and gave the stock a “buy” rating in a research note on Thursday, July 27th. BidaskClub upgraded shares of Advanced Accelerator Applications from a “hold” rating to a “buy” rating in a research report on Friday, July 14th. Zacks Investment Research upgraded shares of Advanced Accelerator Applications from a “hold” rating to a “buy” rating and set a $44.00 price target for the company in a research report on Tuesday, July 11th. Jefferies Group LLC restated a “buy” rating and set a $60.00 price target (up previously from $50.00) on shares of Advanced Accelerator Applications in a research report on Friday, September 1st. Finally, JMP Securities lowered shares of Advanced Accelerator Applications from an “outperform” rating to a “market perform” rating in a research report on Monday.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/11/03/advanced-accelerator-applications-s-a-aaap-receives-average-rating-of-buy-from-brokerages.html.
Several institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. lifted its holdings in shares of Advanced Accelerator Applications by 9.1% in the third quarter. Alps Advisors Inc. now owns 43,308 shares of the company’s stock worth $2,928,000 after buying an additional 3,614 shares in the last quarter. Birchview Capital LP raised its stake in Advanced Accelerator Applications by 10.0% in the third quarter. Birchview Capital LP now owns 22,000 shares of the company’s stock valued at $1,488,000 after purchasing an additional 2,000 shares in the last quarter. Empirical Finance LLC purchased a new stake in Advanced Accelerator Applications in the third quarter valued at approximately $265,000. Reliance Trust Co. of Delaware purchased a new stake in Advanced Accelerator Applications in the third quarter valued at approximately $596,000. Finally, PointState Capital LP purchased a new stake in Advanced Accelerator Applications in the second quarter valued at approximately $5,247,000. 37.53% of the stock is currently owned by hedge funds and other institutional investors.
Advanced Accelerator Applications (NASDAQ AAAP) traded down $0.04 during trading on Friday, reaching $80.99. The company’s stock had a trading volume of 700,344 shares, compared to its average volume of 1,179,046.
Advanced Accelerator Applications (NASDAQ:AAAP) last posted its earnings results on Thursday, August 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.01). Advanced Accelerator Applications had a negative return on equity of 16.05% and a negative net margin of 33.83%. The firm had revenue of $40.14 million during the quarter, compared to the consensus estimate of $36.74 million. analysts expect that Advanced Accelerator Applications will post -0.75 EPS for the current fiscal year.
About Advanced Accelerator Applications
Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.
What are top analysts saying about Advanced Accelerator Applications S.A.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Advanced Accelerator Applications S.A. and related companies.